Vuzix (VUZI) Q2 2024 earnings summary

Executive summary

• Q2 2024 saw a 77% year-over-year sales decline to $1.1M, driven by an 86% drop in product sales, while engineering services rose 85% to $491K.

• Net loss for Q2 2024 was $40.6M ($0.62/share), compared to $9.0M ($0.14/share) in Q2 2023, primarily due to a $30.1M non-cash impairment charge related to Atomistic.

• Significant cost reductions and organizational rightsizing were implemented, including payroll and staff cuts, reducing annual costs by $8M and weekly salary costs by 38%.

• Strategic shift toward OEM and waveguide supply, with ongoing partnerships and a robust OEM pipeline targeting enterprise, defense, and consumer markets.

• Management is actively pursuing strategic deals and may seek additional equity financing via a $50M at-the-market offering to address liquidity risks.

Financial highlights

• Q2 2024 revenue was $1.1M, with product sales at $0.6M (down 86%) and engineering services at $0.5M (up 85%).

• Gross loss of $0.3M (gross margin -30%) versus a $1.0M gross profit (21% margin) in Q2 2023, driven by lower sales and high fixed costs.

• Net loss of $40.6M included a $30.1M impairment charge; cash and equivalents at $9.9M, working capital at $22.1M as of June 30, 2024.

• Six-month sales fell 65% year-over-year to $3.1M; accumulated deficit reached $344.6M.

Outlook and guidance

• Management expects revenue improvement in H2 2024, with at least one defense and one commercial OEM project moving into production, and potential $10–14M revenue from the defense contract.

• Annual cost structure reduced by $8M through headcount cuts and salary reductions; further cost controls include curtailing R&D and delaying CapEx.

• Break-even requires $16–20M in annual margin, with operating costs targeted at $4M per quarter.